Pothineni, Krishna

Chief Fellow

Medical School : Gandhi Medical College, Secunderabad, India

Residency : University of Arkansas for Medical Sciences

Career Interest : Electrophysiology

Research Interest : Safety of catheter ablation, LOX-1 in atherogenesis

Hobbies: Running, Volleyball


Selected Publications

  1. Pothineni NV, Delongchamp R, Vallurupalli S, Ding Z, Dai Y, Hagedorn CH, Mehta JL. Impact of hepatitis C seropositivity on the risk of coronary heart disease events. Am J Cardiol. 2014 Dec 15;114(12):1841-5.
  2. Pothineni NV, Deshmukh A, Padmanabhan D, Kovelamudi S, Patel NJ, Badheka AO, Mulpuru SK, Paydak H, Noseworthy PA. Complication rates of ventricular tachycardia ablation: Comparison of safety outcomes derived from administrative databases and clinical trials. Int J Cardiol. 2015 Dec 15;201:529-31.
  3. Pothineni NV, Deshmukh A, Pant S, Patel NJ, Badheka A, Chothani A, Shah N, Mehta K, Savani GT, Singh V, Grover P, Bhalara V, Patel N, Arora S, Rathod A, Viles-Gonzalez J, Paydak H. Complication rates of atrial fibrillation ablations: Comparison of safety outcomes from real world to contemporary randomized control trials. Int J Cardiol. 2014 Aug 1;175(2):372-3.
  4. Pothineni NV, Hayes K, Deshmukh A, Paydak H. Propofol-related infusion syndrome: Rare and fatal. Am J Ther. 2015 Mar-Apr;22(2):e33-5.
  5. Pothineni NV, Mehta JL. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015 Sep 3;373(10):977-8.
  6. Pothineni NV, Rochlani Y, Vallurupalli S, Kovelamudi S, Ahmed Z, Hakeem A, Mehta JL. Comparison of angiographic burden of coronary artery disease in patients with versus without hepatitis C infection. Am J Cardiol. 2015 Oct 1;116(7):1041-4.
  7. Pothineni NV, Shah NS, Rochlani Y, Nairooz R, Raina S, Leesar MA, Uretsky BF, Hakeem A. U.S. trends in inpatient utilization of fractional flow reserve and percutaneous coronary intervention. J Am Coll Cardiol. 2016 Feb 16;67(6):732-3.
  8. Pothineni NV, Shirazi LF, Mehta JL. Gender differences of autonomic control of the cardiovascular system. Curr Pharm Des. 2016 May 18
  9. Pothineni NV, Watts TE, Ding Z, Dai Y, Deshmukh AJ. Eptifibatide-induced thrombocytopenia–when inhibitor turns killer. Am J Ther. 2016 Jan-Feb;23(1):e298-9.
  10. Pothineni NV, Ding Z, Mehta JL. Is Irisin a marker of statin induced myopathy? Bench to bedside. Clinical Lipidology. December 2013 ,Vol. 8, No. 6, Pages 623-625.
  11. Pothineni N, Sureddi R, Paydak H. Disseminated Intravascular Coagulation after Radiofrequency Catheter Ablation of Idiopathic Ventricular Tachycardia. The Journal of Innovations in Cardiac Rhythm Management, 4 (2013), 1183–1186.
  12. Pothineni NV, Bahia A, Gobal F, Ahmed Z, Uretsky BF, Hakeem A. “DVT” of the heart: A “novel” treatment for an old problem. JACC Cardiovasc Interv. 2015 Aug 24;8(10):e165-6.
  13. Deshmukh A, Pothineni NV, Patel N, Badheka A, Mulpuru SK, Paydak H, Noseworthy PA. Trends in hospitalizations of young patients with atrial fibrillation: A cause for concern? Int J Cardiol. 2016 Jan 15;203:164-5.
  14. Mehta JL, Pothineni NV. Inflammation in heart failure: The holy grail? Hypertension. 2016 May 9.
  15. Vallurupalli S, Pothineni NV, Deshmukh A, Paydak H. Utility of routine exercise testing to detect rate-related QRS widening in patients without structural heart disease on class ic antiarrhythmic agents (flecainide and propafenone). Am J Cardiol. 2015 Sep 1;116(5):730-2.
  16. Rochlani Y, Pothineni NV, Mehta JL. Metabolic syndrome: Does it differ between women and men? Cardiovasc Drugs Ther. 2015 Aug;29(4):329-38.
  17. Deshmukh A, Pothineni NV, Pant S, Paydak H. Pacemaker lead malposition: When right is not right! Arch Cardiovasc Dis. 2014 Mar;107(3):201-2.
  18. Rochlani YM, Shah NN, Pothineni NV, Paydak H. Utilization and predictors of electrical cardioversion in patients hospitalized for atrial fibrillation. Cardiol Res Pract. 2016;2016:8956020.
  19. Shah N, Rochlani Y, Pothineni NV, Paydak H. Burden of arrhythmias in patients with multiple myeloma. Int J Cardiol. 2016 Jan 15;203:305-6.
  20. Dai Y, Mercanti F, Dai D, Wang X, Ding Z, Pothineni NV, Mehta JL. LOX-1, a bridge between GLP-1R and mitochondrial ROS generation in human vascular smooth muscle cells. Biochem Biophys Res Commun. 2013 Jul 19;437(1):62-6.
  21. Nairooz R, Ayoub K, Sardar P, Payne J, Almomani A, Pothineni NV, Shailesh F, Aronow WS, Mukherjee D. Uninterrupted new oral anticoagulants compared with uninterrupted vitamin K antagonists in ablation of atrial fibrillation: A meta-analysis. Can J Cardiol. 2015 Sep 26.
  22. Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F, Mehta JL. Inflammation and atherosclerosis–revisited. J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):170-8.
  23. Nairooz R, Valgimigli M, Rochlani Y, Pothineni NV, Raina S, Sardar P, Mukherjee D, Naidu SS, Shavelle DM. Meta-analysis of clopidogrel pretreatment in acute coronary syndrome patients undergoing invasive strategy. Int J Cardiol. 2017 Feb 15;229:82-89.
  24. Hakeem A, Edupuganti MM, Almomani A, Pothineni NV, Payne J, Abualsuod AM, Bhatti S, Ahmed Z, Uretsky BF. Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve. J Am Coll Cardiol. 2016 Sep 13;68(11):1181-91.
  25. Raina S, Lensing SY, Nairooz RS, Pothineni NV, Hakeem A, Bhatti S, Pandey T. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis. JACC Cardiovasc Imaging. 2016 Nov;9(11):1267-1277.
  26. Kasula S, Agarwal SK, Hacioglu Y, Pothineni NK, Bhatti S, Ahmed Z, Uretsky B, Hakeem A. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes. Heart. 2016 Dec 15;102(24):1988-1994.
  27. Pothineni NV, Shirazi LF, Mehta JL. Gender Differences in Autonomic Control of the Cardiovascular System. Curr Pharm Des. 2016;22(25):3829-34.